| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.257 | 0 | 0 | 18.475 | 2.806 | 0 | 0 | 395 | 14.137 | 19.308 |
| Total Income - EUR | 7.257 | 0 | 0 | 18.475 | 2.806 | 0 | 0 | 395 | 14.137 | 19.308 |
| Total Expenses - EUR | 11.654 | 22 | 44 | 7.789 | 5.978 | 6.608 | 246 | 350 | 10.154 | 11.114 |
| Gross Profit/Loss - EUR | -4.397 | -22 | -44 | 10.686 | -3.173 | -6.608 | -246 | 45 | 3.983 | 8.194 |
| Net Profit/Loss - EUR | -4.615 | -22 | -44 | 10.646 | -3.237 | -6.608 | -246 | 33 | 3.316 | 6.865 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Orl Acsimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 45.169 | 39.131 | 32.947 | 32.216 | 32.316 | 26.128 | 19.421 |
| Current Assets | 23.353 | 23.088 | 22.646 | 4.474 | 2.291 | 1.496 | 1.434 | 352 | 0 | 3.771 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104 | 0 | 0 |
| Receivables | 23.225 | 22.988 | 22.599 | 4.381 | 1.501 | 1.320 | 1.230 | 0 | 0 | 438 |
| Cash | 128 | 100 | 46 | 93 | 790 | 175 | 204 | 247 | 0 | 3.333 |
| Shareholders Funds | 10.431 | 10.302 | 10.084 | 21.405 | 17.753 | 10.809 | 10.323 | 10.389 | 13.674 | 20.462 |
| Social Capital | 225 | 223 | 219 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 12.922 | 12.786 | 12.561 | 28.238 | 23.669 | 23.634 | 23.327 | 24.729 | 12.454 | 2.730 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Orl Acsimed S.r.l.